Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 4 minute read Pharma Industry News Scinai Immunotherapeutics secures Italian approval to advance Pincell acquisition and PC111 development Scinai Immunotherapeutics receives Italian Golden Power clearance for proposed Pincell buyout, moving closer to advancing PC111 monoclonal antibody program. byPallavi MadhirajuJune 7, 2025